Volatile Biotech Could Give Your Portfolio a Boost

Buy Vertex Pharmaceuticals on declines using a limit order price of $46. More 

9 Biotech Buyout Players to Watch

The deal between Human Genome Sciences and GlaxoSmithKline is just the most recent of big pharma buyouts -- and these biotech players could be next. More 

Top 6 Stocks to Buy for July

This month’s emphasis is on stocks that should do well despite near-term market concerns. More 

Clinical Trial Error Sends Vertex Shares Down

Vertex Pharmaceuticals saw its shares drop more than 14% in Tuesday trading on news of a mistake in clinical trials of its new cystic fibrosis treatments. More 

7 Biotech Stocks to Add to Your Portfolio

The biotech business is working overtime to find the next breakthrough drugs and treatments for a population that gets older every day. More 

7 Biotech Stocks to Buy

With an aging U.S. population in need of healthcare, biotech stocks will grow with the demographic, providing an excellent chance to buy these 7 stocks. More 

Amazon Skewered After Hours — Tuesday’s IP Market Recap

And Netflix, RadioShack got beat up during the day. More